Navitas Life Sciences

WhitePaper - Discovering Value with Terminated Drugs and Studies

Terminated Drugs and Studies, High Costs with No Return

Developing new drugs is a difficult and costly challenge for the Life Science industry.

The cost of bringing a new drug to market is estimated somewhere between 1 and 5 billion dollars. One of the largest costs in bringing a drug to market is the clinical trial process, most studies fail as many compounds fall by the way side for various reasons, incurring heavy costs which continue to accrue after termination.

Download this white paper to learn:

  • How you can achieve financial benefits by utilizing outsourcing for terminated study reporting
  • Reducing Costs and Releasing Internal Resources
  • Sponsor costs Conversion per study
  • How to meet regulations with minimal effort and resources
Please complete form to download Whitepaper
First Name
Last Name
Business Email
Company
Job Title
Country
By submitting this form, I agree to receive email communications from Navitas Life Sciences. View Navitas Life Sciences' Privacy Policy

© 2018 Navitas Life Sciences | A TAKE Solutions Enterprise  | privacy policy